Herein, we described the self-assembly of a triblock copolymer, poly(styrene-b-2-vinylpyridine-b-ethylene oxide) (PS-b-P2VP-b-PEO), in THF/water at room temperature to form segmented wormlike nanostructures. We found two different formation mechanisms of the segmented wormlike nanostructures from PS-b-P2VP-b-PEO with different molecular weights. Moreover, the dimension of such segmented wormlike nanostructures depends on the stirring rate. Interestingly, these wormlike nanostructures disassembled gradually when increasing the temperature, which is reversible. After cooling to room temperature the segmented wormlike micelles reformed gradually with stirring. Furthermore, neither intense stirring nor ultrasonic vibration could damage the structure of these wormlike nanostructures which proves their stability and potential application as drug delivery vehicles.Herein, PS-b-P2VP-b-PEO could self-assemble to form a kind of segmented wormlike nanostructures. Two formation mechanisms were observed. Moreover, such segmented wormlike nanostructures disassembled gradually when increasing the temperature.相似文献
Pseudorabies virus (PRV) primarily infects swine but can infect cattle, dogs, and cats. Several studies have reported that PRV can cross the specie barrier and induce human encephalitis, but a definitive diagnosis of human PRV encephalitis is debatable due to the lack of PRV DNA detection. Here, we report a case of human PRV encephalitis diagnosed by the next-generation sequencing (NGS) of PRV sequences in the cerebrospinal fluid (CSF) of a patient. A male pork vendor developed fever and seizures for 6 days. NGS results showed PRV sequences in his CSF and blood. Sanger sequencing showed that PRV DNA in the CSF and PRV antibodies in both the CSF and blood were positive. MRI results revealed multiple inflammatory lesions in the bilateral hemisphere. Based on the clinical and laboratory data, we diagnosed the patient with PRV encephalitis. This case suggests that PRV can infect humans, causing severe viral encephalitis. People at risk of PRV infection should improve their self-protection awareness.
During the process of developing a slow-release formulation of indapamide, researchers created a drug-containing pellet coated with Eudragit RS100 (Rohm GMbH & Co. KG, Darmstadt, Germany) to control the rate at which the drug was released. The two main variables were the agglomerants used in the pellet preparation and the amount of Eudragit RS100 used to coat them. The optimal outcome was indicated by the greatest number of drug-containing pellets recovered through an 18- to 24-mesh sieve and a satisfactory 24-hour release curve. The kinetics of dissolution fit the Higuchi kinetics model. Stability tests of the drug pellets showed no notable changes in the rate of drug release, related substances (mean byproducts or impurities from interactions or decompositions), and drug content. 相似文献